Sudarshan Chemical Industries Limited has informed the Exchange about General UpdatesIn continuation to the submission of results made today, We are again submitting the results with standalone limited review report containing UDIN as provided by the statutory auditors. We are unable to upload the same under the prescribed path of NSE and hence we are submitting it under head General Updates
SUDARSCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Chemical Industries reported its Q3 FY26 (quarter ended 31 December 2025) and 9M FY26 unaudited results along with a renewal of a corporate guarantee of up to €6 million for its wholly owned subsidiary Sudarshan Europe B.V. On a standalone basis, revenue from operations fell to ₹550.3 crore in Q3 (vs ₹574.8 crore YoY) and to ₹1,664.0 crore in 9M FY26 (vs ₹1,830.4 crore YoY), an ~9% decline. Standalone profit after tax, however, grew sharply to ₹22.5 crore in Q3 (vs ₹16.1 crore) and ₹169.9 crore in 9M (vs ₹118.6 crore, ~43% growth), aided by foreign exchange gains and lower costs. On a consolidated basis, revenue surged to ₹6,997.3 crore in 9M FY26 (from ₹1,996.1 crore YoY) on inclusion of the Heubach pigment business acquired in March 2025, but the company reported a consolidated loss of ₹116.0 crore in Q3 and ₹41.7 crore in 9M, weighed down by exceptional items of ₹45.4 crore (Labour Codes impact and Heubach integration/restructuring costs). The auditor SRBC & Co LLP issued an unqualified limited review report on both sets of results.
Standalone profitability remains healthy with strong YoY PAT growth despite a mild revenue dip, but the consolidated picture shows Heubach integration pressures with negative bottom-line and significant exceptional charges, which may concern investors. The €6 million corporate guarantee renewal for the European subsidiary is routine working capital support and not material at the group level.